Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction

C Beckwith, MA Munger - Annals of Pharmacotherapy, 1993 - journals.sagepub.com
OBJECTIVE: To discuss the effects of angiotensin-converting enzyme (ACE) inhibitors on
ventricular remodeling and survival after acute myocardial infarction (AMI). An overview is …

Ventricular enlargement following infarction is a modifiable process

MA Pfeffer, E Braunwald - The American journal of cardiology, 1991 - Elsevier
The dilation and distortion of the left ventricle that may occur as a consequence of
myocardial infarction are associated with a heightened risk for adverse cardiovascular …

Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II

HM Stauss, YC Zhu, T Redlich… - Journal of …, 1994 - journals.sagepub.com
Background: The beneficial effects of angiotensin-converting enzyme (ACE) inhibitors in the
prevention of heart failure following myocardial infarction are widely accepted. However, the …

Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats

LAM Zornoff, BB Matsubara, LS Matsubara… - Basic Research in …, 2000 - Springer
Background: ACE inhibitors have shown beneficial results in several studies after
myocardial infarction (MI). However, this studies have shown conflicting results about the …

Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts

DC Lefroy, T Crake, F Del Monte… - American Journal …, 1996 - journals.physiology.org
The effects of angiotensin II on myocardial contractility were assessed in isolated cardiac
myocyte preparations, using video microscopy with a computerized edge-detection system …

Captopril: a review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease

GL Plosker, D McTavish - Drugs & Aging, 1995 - Springer
Synopsis Captopril is an angiotensin converting enzyme (ACE) inhibitor which has been
used extensively in the treatment of patients with hypertension and congestive heart failure …

Captopril in cardioplegia and reperfusion: protective effects on the ischemic heart

J Gurevitch, D Pevni, MD Inna Frolkis, M Matsa… - The Annals of thoracic …, 1997 - Elsevier
Background. Previous studies have shown that long-term treatment with the angiotensin-
converting enzyme inhibitor captopril attenuates left ventricular dilatation and improves …

[图书][B] Myocardial ischemia: mechanisms, reperfusion, protection

M Karmazyn - 2013 - books.google.com
Myocardial ischemia and subsequent reperfusion of the ischemic myocardium represent
complex phenomena encompassing numerous physiological processes. This book aims at …

Potential role for antiangiogenic proteins in the myocardial infarction repair process

JL Thompson, JA Ryan, ML Barr, B Franc… - Journal of Surgical …, 2004 - Elsevier
OBJECTIVE: Although angiogenic proteins have been identified as positive modulators of
myocardial revascularization following acute myocardial infarction, little if anything is known …

Mechanisms of subcellular remodelling in post-infarct heart failure

NS Dhalla, D Kaura, X Liu, RE Beamish - Myocardial ischemia …, 1996 - Springer
Occlusion of a coronary artery results in myocardial ischemia and subsequent myocardial
infarction. Whenever the infarct size is more than 30% of the ventricular wall, the remaining …